Three studies advance blood tests for detecting CTE in living people
The gist
Three separate research teams reported blood-based markers that may help identify CTE, a brain disease now confirmed only at autopsy.
A living-patient test would open the door to clinical trials and earlier diagnosis.
How it unfolded
- Nov 13, 2026A Washington University School of Medicine in St. Louis study in JAMA found the Alzheimer's blood biomarker eMTBR-tau243 is also elevated in advanced CTE, testing blood from 11 people whose CTE was confirmed at autopsy among 229 participants.
- Nov 13, 2026The same study found the test distinguished advanced CTE from healthy people with high accuracy but could not reliably identify early-stage CTE; levels in CTE were much lower than in Alzheimer's disease.
- Nov 18, 2026A Mass General Brigham, Boston University and Concussion & CTE Foundation review in JAMA Network Open of 12 studies covering 4,421 deceased individuals found CTE pathology in 29, or 0.66%.
Key terms
- CTE
- A neurodegenerative brain disease caused by repeated head trauma, leading to mood, behavior, and thinking problems that worsen over time.
- biomarker
- A measurable biological indicator of a body's state or condition, often tested in blood, urine, or tissue.
- autopsy
- A surgical examination of a corpse by dissection to determine the cause, mode, and manner of death.
Source: Wikipedia